Tag: FDA
Aspartame under scrutiny for being a ‘possible carcinogen’
Aspartame, one of the most commonly used artificial sweeteners, is now under scrutiny over cancer concerns. It is been used in products such as...
FDA discovers multiple faults at Aurbindo Pharma
US Food and Drug Administration (FDA) found multiple faults at a plant run by one of India’s biggest drugmakers Aurbindo Pharma. Auditors uncovered deficient...
Rinvoq to see rapid uptake by healthcare providers for Crohn’s Disease
The FDA recently announced the approval of Rinvoq, AbbVie’s Janus kinase inhibitor (JAKi), to treat adults with moderately to severely active Crohn’s Disease (CD)...
Declining FDA nod may hit pharma contract makers
Pharma manufacturers will feel the effects of high inflation and declining Food and Drug Administration (FDA) drug approvals in 2023, says GlobalData, a data...
Lupin receives FDA nod for Glycopyrrolate injection, USP
Global pharma major Lupin has announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New...
US FDA bid to strengthen drug supply chain
27 November 2023 is the US Food and Drug Administration's (FDA) deadline for compliance with the Drug Supply Chain Security Act (DSCSA), which aims...
FDA approves new breakthrough Alzheimer’s drug
The US Food and Drug Administration (FDA) on 6 January approved lecanemab, the second of a new category of medications approved for Alzheimer’s disease...
Natural Products Association team meets FDA on anti-aging ingredient, NMN
Representatives of the Natural Products Association (NPA) recently met FDA officials in response to a recent determination by regulators that an anti-aging ingredient, β-NMN...
FDA warns companies selling supplements over ‘false’ claims
The US Food and Drug Administration(FDA) has issued warnings to seven companies for illegally selling dietary supplements in violation of the Federal Food, Drug,...
Philips announces advances in MR workflow
Royal Philips, a global provider in health technology, recently announced two new advances in MR-only workflows to advance head and neck cancer radiotherapy imaging...